Oscar Health, Inc.
OSCR
$31.76
-$1.25-3.79%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.29B | 13.27B | 11.67B | 11.26B | 10.71B |
| Total Other Revenue | 29.58M | 29.98M | 28.59M | 24.44M | 20.54M |
| Total Revenue | 15.32B | 13.30B | 11.70B | 11.29B | 10.73B |
| Cost of Revenue | 12.23B | 10.99B | 10.02B | 9.46B | 8.88B |
| Gross Profit | 3.09B | 2.31B | 1.68B | 1.82B | 1.84B |
| SG&A Expenses | 2.43B | 2.27B | 2.05B | 2.00B | 1.94B |
| Depreciation & Amortization | 28.27M | 29.18M | 28.89M | 30.25M | 30.43M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.69B | 13.29B | 12.10B | 11.50B | 10.86B |
| Operating Income | 629.72M | 10.61M | -396.36M | -210.34M | -129.47M |
| Income Before Tax | 589.81M | -26.74M | -437.30M | -238.31M | -151.33M |
| Income Tax Expenses | 38.88M | 12.65M | 5.61M | 5.45M | 9.33M |
| Earnings from Continuing Operations | 550.93 | -39.39 | -442.90 | -243.75 | -160.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -190.00K | -40.00K | -248.00K | -333.00K | -575.00K |
| Net Income | 550.74M | -39.43M | -443.15M | -244.09M | -161.23M |
| EBIT | 629.72M | 10.61M | -396.36M | -210.34M | -129.47M |
| EBITDA | 657.96M | 39.79M | -367.47M | -180.10M | -99.03M |
| EPS Basic | 1.70 | -0.39 | -1.57 | -0.95 | -0.64 |
| Normalized Basic EPS | 1.14 | -0.22 | -0.97 | -0.58 | -0.38 |
| EPS Diluted | 1.39 | -0.60 | -1.76 | -1.19 | -0.88 |
| Normalized Diluted EPS | 0.93 | -0.36 | -1.10 | -0.71 | -0.51 |
| Average Basic Shares Outstanding | 1.14B | 1.10B | 1.05B | 1.01B | 998.13M |
| Average Diluted Shares Outstanding | 1.21B | 1.13B | 1.10B | 1.07B | 1.05B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |